Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
Clinical trial NCT00670592 · COMPLETED
Trial details
- NCT number
- NCT00670592
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2013-02-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.